CD45, panCK, and HER2 antibodies were used to distinguish the immune cell (CD45+), normal epithelium (panCK+, HER2−) and tumor cell (panCK+, HER2+) compartments (Figure 2A). This evidence concerns the gene ERBB2 and neoplasm.